Bulk Inquiry
PLX 4032
- RG 7204 - Vemurafenib - RO 5185426
- Soluble in DMSO
- MF: C23H18ClF2N3O3S
- MW: 489.92
Description
More Information
| Parent CAS No. | 918504-65-1 |
|---|---|
| Chemical Name | N-(3-(5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide |
| SMILES | C(C1C(=CC=C(NS(=O)(=O)CCC)C=1F)F)(C1=CNC2=NC=C(C3C=CC(Cl)=CC=3)C=C12)=O |
| MFCD | N.A. |
| InChi | InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28) |
| InChiKey | GPXBXXGIAQBQNI-UHFFFAOYSA-N |
| CID | 42611257 |
| Short Description | B-Raf inhibitor |
References
- G Bollag et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 2010, 467, 596–599.
- PI Poulikakos et al. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature 2010, 464, 427-430.
- E Sala et al. BRAF Silencing by Short Hairpin RNA or Chemical Blockade by PLX4032 Leads to Different Responses in Melanoma and Thyroid Carcinoma Cells. Mol. Cancer Res. 2008, 6(5), 751-759.
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1397 | Sorafenib tosylate |
From $77.00 |
| 1459 | GDC 0879 |
From $77.00 |
| 1474 | PLX 4720 |
From $55.00 |
| 1545 | AZ 628 |
From $88.00 |
| 1984 | GW 5074 |
From $93.50 |
| 2438 | Cuspin-1 |
From $104.50 |
| 2504 | SB 590885 |
From $104.50 |
| 2590 | Locostatin |
From $66.00 |
| 2817 | RAF709 |
From $132.00 |
| 3067 | Belvarafenib |
From $126.50 |
| 3351 | Sorafenib |
From $66.00 |
| 3556 | LXH254 |
From $198.00 |
| 3862 | BGB-283 |
From Inquiry |
| 4033 | TAK-632 |
From Inquiry |
| 4146 | LGX818 |
From Inquiry |
Other Categories
Are you sure you would like to remove this item from the shopping cart?
This item is a part of the approved quote. Removing it will remove all quote items from the cart.